NIH Information Quality
NTP Technical Report on the Toxicology and Carcinogenesis Studies of Alpha-Pinene (CASRN 80-56-8) Administered by Inhalation to Sprague Dawley (Hsd: Sprague Dawley® SD®) Rats, B6C3F1/N Mice, and CD1 Mice
| Document, Report, or Other Product Information | |
|---|---|
| Title: | NTP Technical Report on the Toxicology and Carcinogenesis Studies of Alpha-Pinene (CASRN 80-56-8) Administered by Inhalation to Sprague Dawley (Hsd: Sprague Dawley® SD®) Rats, B6C3F1/N Mice, and CD1 Mice |
| Subject: | The National Toxicology Program conducted 2-year toxicology and carcinogenesis studies of alpha-pinene in rodents to evaluate long-term toxicity and potential to cause cancer. |
| Purpose (e.g., abstract): | To conduct external peer review of the 2-year studies. |
| Information Product Contact | |
| ISI or HISA: | ISI |
| Link to Information Product: | |
| IC: | NIEHS |
| IC Division, Office, or Program: | Division of Translational Toxicology |
| NIH Contact: | Milene
Brownlow 984-287-3364 [email protected] |
| Reviewer Names and Expertise: | |
| Review Description: | External peer review of the technical and scientific elements of the study and whether they support the conclusions. |
| Date of Review: | 2025-02-28 |
| Number of Reviewers: | 6 |
| Reviewer Nominations Requested? | |
| Upcoming Panels, Events: | View Upcoming Panels, Events, Notices, Meeting Updates |
| Technical/Draft Reports, Public Comments and Presentations: | |
| Past Roster, Notices, Meeting Updates: | View Past Roster, Notices, Meeting Updates |
| Reviewer Expertise: | carcinogenicity, general pathology, molecular pathology, reproductive pathology and toxicology, inhalation toxicology, general toxicology, monoterpenes |
| How Selected: | NTP selected from scientific experts, taking into account expertise, gender, geographical location and COI screening. |
| Opportunity for Public Comment? | NO |
| Did any reviewers require any exception to the applicable independence or COI standards of the Bulletin, including determination by the Sec./Dep. Sec. pursuant to Section (3)(c)? | NO |
| Were any waivers, deferrals, exemptions, or alterative peer review processes used? | NO |
| Any Public Meetings? | NO |
| Number of Public Comments Received | |
This page last reviewed on